A new challenge for control selection in influenza vaccine effectivenes test-negative design studies in the COVID-19 context: Results from the European I-MOVE multicentre study at primary care level (CROSBI ID 728356)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Kissling, Esther et al
engleski
A new challenge for control selection in influenza vaccine effectivenes test-negative design studies in the COVID-19 context: Results from the European I-MOVE multicentre study at primary care level
Although 31% of controls were positive for SARS-CoV- 2, excluding them increases IVE estimates by <10% overall, and only 3% in the vaccination target group.
COVID-19 ; vaccination ; influenza ; case-control studies ; multicentre study
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
54-54.
2022.
objavljeno
Podaci o matičnoj publikaciji
Abstract book: ESCAIDE:European Scientific Conference on Applied Infectious DIsease Epidemiolgy
Catchpole, Mike
Stockholm: ECDC
Podaci o skupu
European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE 2022)
poster
23.11.2022-25.11.2022
Stockholm, Švedska
